CRSP - Why CRISPR Therapeutics Stock Is Moving Higher Monday | Benzinga
CRISPR Therapeutics AG (NYSE: CRSP) shares are trading higher Monday after the company announced preclinical data for its investigational programs for the treatment of cardiovascular disease.
What Happened: CRISPR is set to announce preclinical data at the American Heart Association (AHA) Scientific Sessions 2023 on Nov. 11. The data will be presented in two sessions.
One of the ...